Skip to content
监管与产业动态评分53

AbbVie's Cerevel buyout delivers as FDA gives go-ahead to 1st-in-class Juvmo in Parkinson's disease - Fierce Pharma

Original articleChinese edition

No English body on site. Use the original article link above.